Mylan Says Generic Parkinson's Drug Approved
NEW YORK (AP) — Mylan Inc. said Wednesday it started selling a generic version of Bristol-Myers Squibb Co.'s Parkinson's disease drug Sinemet.
The Food and Drug Administration approved the drug in three doses, the Pittsburgh-based company said. It launched the generic tablets after gaining approval. Sinemet is a common Parkinson's disease treatment containing two drugs, levodopa and carbidopa. Mylan said U.S. sales totaled $79 million for the 12 months ended June 30. In morning trading, Mylan shares lost 28 cents to $15.87. Shares of New York-based Bristol-Myers Squibb rose 3 cents to $22.60.- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
-
In Health Reform, Boons for Hospitals and Drug Makers
New York Times
-
Junk Bonds Selling at Briskest Pace Since 2007: Credit Markets
BusinessWeek Online
-
BA facing busiest day of strike
BBC
-
Virginia firms that recently filed for bankruptcy
Washington Post
-
House Begins Debate On Health-Care Bill As Protesters Gather
FOXBusiness.com
-
Interest-Rate Deals Sting Cities
The Wall Street Journal.
-
Courting Google, City Fathers Turn to Silliness
New York Times
-
Report: China Losing Support of American Business Community
Calculated Risk
-
Oil Prices and Vehicle Miles
Calculated Risk
-
Failed Brands Get New Life
The Wall Street Journal.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,744.78 | 1,159.18 | 2,375.57 | 36.68 |
Oil *
78.27
|
|
UP
2.80
|
DOWN
0.72
|
UP
1.16
|
DOWN
0.19
|
10 Yr
3.67%
SPDR Gold
107.13
|
|
+0.03%
|
-0.06%
|
+0.05%
|
-0.52%
|
Data delayed 20 minutes |
More From TheStreet
Latest HeadlinesBrokerage Partners
Sponsored Links














